Companies / Ligand Pharmaceuticals Inc / Activity
Activity — Ligand Pharmaceuticals Inc
16 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Next Century Growth Investors LLC 13F manager | New | Common stock | $19.14M | +96K | 95,876 0.48% of shares | medium |
| Q1 2026 as of | Palisade Capital Management, LP 13F manager | New | Common stock | $4.10M | +21K | 20,525 0.10% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common stock | $1.50M | +8K | 7,505 0.04% of shares | low |
| Q2 2026 as of | JW Asset Management, LLC 13F manager | New | Common stock | $1.26M | +4K | 4,000 0.02% of shares | low |
| Q3 2024 as of | Danske Bank A/S 13F manager | New | Common stock | $875.4K | +9K | 8,746 0.04% of shares | low |
| Q1 2026 as of | Argent Capital Management LLC 13F manager | New | Common stock | $695.8K | +3K | 3,485 0.02% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | New | Common stock | $548.1K | +2K | 1,734 <0.01% of shares | low |
| Q1 2026 as of | ALPS Advisors, Inc. 13F manager | New | Common stock | $487.1K | +2K | 2,440 0.01% of shares | low |
| Q1 2026 as of | Beck Mack & Oliver LLC 13F manager | New | Common stock | $338.2K | +2K | 1,694 <0.01% of shares | low |
| Q1 2026 as of | Graham Capital Management, L.P. 13F manager | New | Common stock | $300.7K | +2K | 1,506 <0.01% of shares | low |
| Q1 2026 as of | Blackstone Inc 13F manager | New | Common stock | $281.9K | +1K | 1,412 <0.01% of shares | low |
| Q2 2026 as of | OneDigital Investment Advisors LLC 13F manager | New | Common stock | $252.9K | +800 | 800 <0.01% of shares | low |
| Q1 2026 as of | Scotia Capital Inc. 13F manager | New | Common stock | $232.4K | +1K | 1,164 <0.01% of shares | low |
| Q4 2025 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $149.6K | +791 | 791 <0.01% of shares | low |
| Q2 2026 as of | CVA Family Office, LLC 13F manager | New | Common stock | $2.8K | +9 | 9 <0.01% of shares | low |
| Q1 2026 as of | Harbor Capital Advisors, Inc. 13F manager | New | Common stock | $139 | +694 | 694 <0.01% of shares | low |